Akero Therapeutics, Inc. (AKRO)

Akero Therapeutics Statistics

Total Valuation

AKRO has a market cap or net worth of $4.47 billion. The enterprise value is $3.48 billion.

Market Cap	4.47B
Enterprise Value	3.48B

Important Dates

The last earnings date was Friday, November 7, 2025, after market close.

Earnings Date	Nov 7, 2025
Ex-Dividend Date	n/a

Share Statistics

AKRO has 82.32 million shares outstanding. The number of shares has increased by 23.38% in one year.

Current Share Class	82.32M
Shares Outstanding	82.32M
Shares Change (YoY)	+23.38%
Shares Change (QoQ)	+0.35%
Owned by Insiders (%)	1.30%
Owned by Institutions (%)	98.91%
Float	70.03M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	4.55
P/TBV Ratio	4.67
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 15.83, with a Debt / Equity ratio of 0.00.

Current Ratio	15.83
Quick Ratio	15.48
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-71.46

Financial Efficiency

Return on equity (ROE) is -34.53% and return on invested capital (ROIC) is -23.81%.

Return on Equity (ROE)	-34.53%
Return on Assets (ROA)	-22.63%
Return on Invested Capital (ROIC)	-23.81%
Return on Capital Employed (ROCE)	-34.45%
Revenue Per Employee	n/a
Profits Per Employee	-$4.65M
Employee Count	63
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +77.28% in the last 52 weeks. The beta is -0.41, so AKRO's price volatility has been lower than the market average.

Beta (5Y)	-0.41
52-Week Price Change	+77.28%
50-Day Moving Average	51.12
200-Day Moving Average	47.98
Relative Strength Index (RSI)	67.11
Average Volume (20 Days)	1,539,382

Short Selling Information

The latest short interest is 4.41 million, so 5.36% of the outstanding shares have been sold short.

Short Interest	4.41M
Short Previous Month	5.81M
Short % of Shares Out	5.36%
Short % of Float	6.30%
Short Ratio (days to cover)	1.21

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-330.02M
Pretax Income	-292.82M
Net Income	-292.82M
EBITDA	-329.99M
EBIT	-330.02M
Earnings Per Share (EPS)	-$3.74

Balance Sheet

The company has $737.83 million in cash and $605,000 in debt, giving a net cash position of $987.71 million or $12.00 per share.

Cash & Cash Equivalents	737.83M
Total Debt	605,000
Net Cash	987.71M
Net Cash Per Share	$12.00
Equity (Book Value)	957.64M
Book Value Per Share	11.95
Working Capital	706.88M

Cash Flow

Operating Cash Flow	-250.17M
Capital Expenditures	n/a
Free Cash Flow	-250.17M
FCF Per Share	-$3.04

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AKRO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-23.38%
Shareholder Yield	-23.38%
Earnings Yield	-6.55%
FCF Yield	-5.60%

Analyst Forecast

The average price target for AKRO is $73.56, which is 35.45% higher than the current price. The consensus rating is "Buy".

Price Target	$73.56
Price Target Difference	35.45%
Analyst Consensus	Buy
Analyst Count	10
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1